Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model
Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model
Inflammatory processes have been implicated in the pathogenesis of brain damage after stroke. In rodent stroke models, focal ischemia induces several proinflammatory chemokines, including monocyte chemoattractant protein-1 (MCP-1). The individual contribution to ischemic tissue damage, however, is largely unknown. To address this question, the authors subjected MCP-1-deficient mice (MCP-1-/-) to permanent middle cerebral artery occlusion (MCAO). Measurement of basal blood pressure, cerebral blood flow, and blood volume revealed no differences between wild-type (wt) and MCP-1-/- mice. MCAO led to similar cerebral perfusion deficits in wt and MCP-1-/- mice, excluding differences in the MCA supply territory and collaterals. However, compared with wt mice, the mean infarct volume was 29% smaller in MCP-1-/- mice 24 hours after MCAO (P = 0.022). Immunostaining showed a reduction of phagocytic macrophage accumulation within infarcts and the infarct border in MCP-1-/- mice 2 weeks after MCAO. At the same time point, the authors found an attenuation of astrocytic hypertrophy in the infarct border and thalamus in MCP-1-/- mice. However, these effects on macrophages and astrocytes in MCP-1-/- mice occurred too late to suggest a protective role in acute infarct growth. Of note: at 6 hours after MCAO, MCP-1-/- mice produced significantly less interleukin-1beta in ischemic tissue; this might be related to tissue protection. The results of this study indicate that inhibition of MCP-1 signaling could be a new acute treatment approach to limit infarct size after stroke.
MCP-1, chemokines, cytokines, neuroinflammation, focal cerebral ischemia, astrocytes, microglia
308-317
Hughes, Paula M.
eb8721bf-bb7f-467b-a9e9-729a7ddcd2e3
Allegrini, Peter R.
4aa513d8-a525-4980-a9d3-67c40b219fe5
Rudin, Markus
d7498c0e-3262-48c8-829e-abbd76bbe127
Perry, V. Hugh
8f29d36a-8e1f-4082-8700-09483bbaeae4
Mir, Anis K.
b01159e3-9191-442a-a633-a2ae73de9492
Wiessner, Christoph
e07aad3d-8f0f-4d46-b5c7-6e7be836b176
March 2002
Hughes, Paula M.
eb8721bf-bb7f-467b-a9e9-729a7ddcd2e3
Allegrini, Peter R.
4aa513d8-a525-4980-a9d3-67c40b219fe5
Rudin, Markus
d7498c0e-3262-48c8-829e-abbd76bbe127
Perry, V. Hugh
8f29d36a-8e1f-4082-8700-09483bbaeae4
Mir, Anis K.
b01159e3-9191-442a-a633-a2ae73de9492
Wiessner, Christoph
e07aad3d-8f0f-4d46-b5c7-6e7be836b176
Hughes, Paula M., Allegrini, Peter R., Rudin, Markus, Perry, V. Hugh, Mir, Anis K. and Wiessner, Christoph
(2002)
Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model.
Journal of Cerebral Blood Flow & Metabolism, 22 (3), .
(doi:10.1097/00004647-200203000-00008).
Abstract
Inflammatory processes have been implicated in the pathogenesis of brain damage after stroke. In rodent stroke models, focal ischemia induces several proinflammatory chemokines, including monocyte chemoattractant protein-1 (MCP-1). The individual contribution to ischemic tissue damage, however, is largely unknown. To address this question, the authors subjected MCP-1-deficient mice (MCP-1-/-) to permanent middle cerebral artery occlusion (MCAO). Measurement of basal blood pressure, cerebral blood flow, and blood volume revealed no differences between wild-type (wt) and MCP-1-/- mice. MCAO led to similar cerebral perfusion deficits in wt and MCP-1-/- mice, excluding differences in the MCA supply territory and collaterals. However, compared with wt mice, the mean infarct volume was 29% smaller in MCP-1-/- mice 24 hours after MCAO (P = 0.022). Immunostaining showed a reduction of phagocytic macrophage accumulation within infarcts and the infarct border in MCP-1-/- mice 2 weeks after MCAO. At the same time point, the authors found an attenuation of astrocytic hypertrophy in the infarct border and thalamus in MCP-1-/- mice. However, these effects on macrophages and astrocytes in MCP-1-/- mice occurred too late to suggest a protective role in acute infarct growth. Of note: at 6 hours after MCAO, MCP-1-/- mice produced significantly less interleukin-1beta in ischemic tissue; this might be related to tissue protection. The results of this study indicate that inhibition of MCP-1 signaling could be a new acute treatment approach to limit infarct size after stroke.
This record has no associated files available for download.
More information
Published date: March 2002
Keywords:
MCP-1, chemokines, cytokines, neuroinflammation, focal cerebral ischemia, astrocytes, microglia
Identifiers
Local EPrints ID: 56503
URI: http://eprints.soton.ac.uk/id/eprint/56503
ISSN: 0271-678X
PURE UUID: d112935e-517a-45aa-a403-6d63d6ab628a
Catalogue record
Date deposited: 07 Aug 2008
Last modified: 15 Mar 2024 11:02
Export record
Altmetrics
Contributors
Author:
Paula M. Hughes
Author:
Peter R. Allegrini
Author:
Markus Rudin
Author:
Anis K. Mir
Author:
Christoph Wiessner
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics